TVTX
USDTravere Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$32.600
High
$34.605
Low
$32.310
Volume
0.26M
Company Fundamentals
Market Cap
3.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.25M
Exchange
NGM
Currency
USD
52-Week Range
Related News
Travere Therapeutics to Participate at Upcoming Investor Conferences
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that company management will participate in the following upcoming investor conferences: Guggenheim's 2nd Annual Healthcare Innovation Conference Presenting
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $35
Piper Sandler analyst Allison Bratzel maintains Travere Therapeutics with a Neutral and raises the price target from $26 to $35.
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $40
TD Cowen analyst Tyler Van Buren maintains Travere Therapeutics with a Buy and raises the price target from $30 to $40.
Travere Therapeutics to Report Third Quarter 2025 Financial Results
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced it will report third quarter 2025 financial results on Thursday, October 30, 2025, after the close of the U.S. financial markets. The Company will host a
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.